SBI Securities
XBIO icon

SBI Securities’s Xenetic Biosciences XBIO Stock Holding History

SBI Securities’s Portfolio XBIO Stock Details XBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.33K Buy
1,003
+3
+0.3% +$9 ﹤0.01% 2532
2026
Q2 		$2.91K Buy
+1,000
New +$3.09K ﹤0.01% 2414
2025
Q4 		– Sell
-5
Closed -$16 – 4250
2025
Q3 		$16 Hold
5
– – ﹤0.01% 3957
2025
Q2 		$20 Hold
5
– – ﹤0.01% 3919
2025
Q1 		$13 Hold
5
– – ﹤0.01% 3930
2024
Q4 		$20 Buy
+5
New +$20 ﹤0.01% 3833

Other funds holding XBIO

Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
HRT Financial
HRT Financial New York $57.2B AUM 52.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
JTC Employer Solutions Trustee
JTC Employer Solutions Trustee St Helier, Jersey $1.16B AUM 24.39% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $273B AUM 15.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Darwin Wealth Management
Darwin Wealth Management Tampa, Florida $378M AUM 15.4% 1-Year Est. Return

SBI Securities's XBIO Position: Q3 2026 in Review

SBI Securities increased its Xenetic Biosciences (XBIO) stake by 0.3% in Q3 2026, buying an estimated $9 and bringing the position to 1,003 shares worth $2.33K. The position accounts for ﹤0.01% of the portfolio, ranked #2532.

SBI Securities first reported a position in XBIO in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.91K in Q2 2026. 12 funds tracked by Wall St. Rank hold XBIO as of Q3 2026.

  • SBI Securities held 1,003 shares of Xenetic Biosciences worth $2.33K as of Q3 2026.
  • SBI Securities bought 3 Xenetic Biosciences shares in Q3 2026, an estimated $9.
  • Xenetic Biosciences made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #2532 holding.
  • SBI Securities first reported a position in Xenetic Biosciences in Q4 2024 and has held it in 6 quarters since.
  • SBI Securities's Xenetic Biosciences position peaked at $2.91K in Q2 2026.
  • 12 funds tracked by Wall St. Rank held Xenetic Biosciences as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.